文献速递免疫规划传染病防控与疫情报告

历史天花疫苗接种与猴痘交叉反应免疫:来自儿童期和成年期暴露医护人员的证据

Historic smallpox vaccination and Mpox cross-reactive immunity: Evidence from healthcare workers with childhood and adulthood exposures.
PubMed 文献 · Vaccine · 2025-01-02

本研究在自报有天花疫苗接种史的个体中观察到针对猴痘的交叉反应免疫,并比较了儿童期与成年期均接种者 versus 仅儿童期接种者的平均抗原反应差异,结果支持儿童期天花疫苗接种可能不足以提供针对多种正痘病毒的持久保护的假说。

要点

  • 自报天花疫苗接种史者中观察到针对猴痘的交叉反应免疫。
  • 儿童期与成年期均接种者 versus 仅儿童期接种者的平均抗原反应存在差异。
  • 结果提示儿童期天花疫苗接种可能不足以提供针对多种正痘病毒的持久保护。

核心结论

  • 在自报有天花疫苗接种史的个体中观察到针对猴痘的交叉反应免疫,儿童期与成年期均接种者 versus 仅儿童期接种者的平均抗原反应存在差异,支持儿童期天花疫苗接种可能不足以提供针对多种正痘病毒的持久保护的假说。

研究设计与样本

  • 本研究在自报有天花疫苗接种史的医护人员中观察针对猴痘的交叉反应免疫,并比较儿童期与成年期均接种者 versus 仅儿童期接种者的平均抗原反应。

主要发现

  • 在自报有天花疫苗接种史的个体中观察到针对猴痘的交叉反应免疫。
  • 儿童期与成年期均接种者 versus 仅儿童期接种者的平均抗原反应存在差异。

临床怎么用

  • 作者认为这些结果可为未来评估将痘苗疫苗重新纳入标准推荐免疫接种的获益提供信息,尤其是在猴痘等正痘病毒流行地区。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In recent years, human mpox has made multiple resurges, prompting public health professionals to consider factors that lead to the increased risk for the reemergence of other orthopoxviruses. Due to the genetic similarity between orthopoxviruses, vaccinia vaccines used to prevent smallpox transmission are also indicated and have been used for mpox infection prevention and control. In this study, cross-reactive immunity for mpox was observed among individuals with self-reported history of smallpox vaccination. Differences in mean antigen response among individuals vaccinated in childhood and adulthood versus individuals vaccinated in childhood only were also observed, supporting the hypothesis that childhood smallpox vaccination may not be sufficient in providing long-lasting protection against multiple orthopoxviruses. These results provide insight on the durability of mpox immunogenic proteins and can be used to inform future studies to assess the benefits of reestablishing vaccinia vaccines as standard recommended immunizations, particularly where orthopoxviruses, such as mpox, are endemic.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Galetti SC, Gadoth A, Halbrook M, et al. Historic smallpox vaccination and Mpox cross-reactive immunity: Evidence from healthcare workers with childhood and adulthood exposures. Vaccine. 2025. PMID: 39752895. doi:10.1016/j.vaccine.2024.126661

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。